Global Leadership

Partnership to End AIDS and Cervical Cancer

Working to effectively eliminate cervical cancer deaths among HIV-positive women in sub-Saharan Africa within a generation.

500K+

Women screen for cervical cancer

32K+

Women treated for pre-cervical cancer lesions

147K+

Girls vaccinated against HPV

Women living with HIV are five times more likely to develop cervical cancer. The Bush Institute, together with its partners PEPFAR and UNAIDS, developed a strategy to save women's lives in sub-Saharan African countries with a high burden of HIV and cervical cancer.

The global health community has made significant progress in reducing the number of deaths from infectious diseases such as HIV/AIDS thanks in large part to the U.S. President's Emergency Plan for AIDS Relief (PEPFAR).  But this work is not complete.

Cervical cancer is highly preventable through the human papillomavirus (HPV) vaccine, screening, and early treatment of pre-cancerous lesions. It is also treatable if detected early.

We work with our partners, PEPFAR and UNAIDS, to prioritize cervical cancer prevention and screening, especially for women living with HIV.

Results

  • More than 500,000 women have been screened for cervical cancer
  • Nearly 32,000 women have been treated for pre-cervical cancer lesions
  • More than 147,000 girls have been vaccinated against HPV.

Global Health

Saving women's lives from cervical cancer in sub-Saharan Africa

Holly Kuzmich
Holly Kuzmich Executive Director of the George W. Bush Institute and Senior Vice President George W. Bush Presidential Center Full Bio
Crystal Cazier
Crystal Cazier Program Manager, Global Health and Evaluation and Research George W. Bush Institute Full Bio